These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15788701)

  • 21. Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.
    Ferraro L; Tomasini MC; Beggiato S; Gaetani S; Cassano T; Cuomo V; Amoroso S; Tanganelli S; Antonelli T
    J Neural Transm (Vienna); 2009 Aug; 116(8):1017-27. PubMed ID: 19533296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia.
    Rawls SM; Cowan A; Tallarida RJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):395-402. PubMed ID: 12235276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum.
    Pintor A; Tebano MT; Martire A; Grieco R; Galluzzo M; Scattoni ML; Pèzzola A; Coccurello R; Felici F; Cuomo V; Piomelli D; Calamandrei G; Popoli P
    Neuropharmacology; 2006 Oct; 51(5):1004-12. PubMed ID: 16895732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure.
    Polissidis A; Chouliara O; Galanopoulos A; Marselos M; Papadopoulou-Daifoti Z; Antoniou K
    Life Sci; 2009 Jul; 85(5-6):248-54. PubMed ID: 19508876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
    Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
    Schneider M; Drews E; Koch M
    Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CB
    Kirson D; Oleata CS; Parsons LH; Ciccocioppo R; Roberto M
    Addict Biol; 2018 Mar; 23(2):676-688. PubMed ID: 28656627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain.
    Moranta D; Esteban S; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):516-24. PubMed ID: 15064921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
    Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
    Németh B; Ledent C; Freund TF; Hájos N
    Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats.
    Chi OZ; Barsoum S; Grayson J; Hunter C; Liu X; Weiss HR
    Pharmacology; 2012; 89(5-6):333-8. PubMed ID: 22678129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
    Wegener N; Koch M
    Brain Res; 2009 Feb; 1253():81-91. PubMed ID: 19094973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.
    Roenker NL; Gudelsky G; Ahlbrand R; Bronson SL; Kern JR; Waterman H; Richtand NM
    Neurosci Lett; 2011 Aug; 500(3):167-71. PubMed ID: 21699956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina.
    Fan SF; Yazulla S
    Vis Neurosci; 2005; 22(1):55-63. PubMed ID: 15842741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats.
    Fernández-López D; Martínez-Orgado J; Nuñez E; Romero J; Lorenzo P; Moro MA; Lizasoain I
    Pediatr Res; 2006 Aug; 60(2):169-73. PubMed ID: 16864698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia.
    Martínez-Orgado J; Fernández-Frutos B; González R; Romero E; Urigüen L; Romero J; Viveros MP
    Brain Res Mol Brain Res; 2003 Jun; 114(2):132-9. PubMed ID: 12829323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
    Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
    Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WIN 55,212-2 Reverted Pilocarpine-Induced Status Epilepticus Early Changes of the Interaction among 5-HT
    Di Maio R; Colangeli R; Di Giovanni G
    ACS Chem Neurosci; 2019 Jul; 10(7):3296-3306. PubMed ID: 30912644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.